Phenotypes of Myopathy-related Actin Mutants in differentiated C2C12 Myotubes by Bathe, Friederike S et al.
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
BMC Cell Biology
Open Access Research article
Phenotypes of Myopathy-related Actin Mutants in differentiated 
C2C12 Myotubes
Friederike S Bathe1, Heidi Rommelaere2 and Laura M Machesky*1
Address: 1School of Biosciences, Division of Molecular Cell Biology, University of Birmingham, Birmingham B15 2TT, UK and 2Flanders 
Interuniversity Institute for Biotechnology (VIB 09) and Department of Biochemistry, Faculty of Medicine and Health Sciences, Ghent University, 
9000, Belgium
Email: Friederike S Bathe - Friedes@gmx.de; Heidi Rommelaere - heidi.rommelaere@ugent.be; 
Laura M Machesky* - l.m.machesky@bham.ac.uk
* Corresponding author    
Abstract
Background: About 20 % of nemaline myopathies are thus far related to skeletal muscle alpha-
actin. Seven actin mutants located in different parts of the actin molecule and linked to different
forms of the disease were selected and expressed as EGFP-tagged constructs in differentiated
C2C12 mytoubes. Results were compared with phenotypes in patient skeletal muscle fibres and
with previous expression studies in fibroblasts and C2C12 myoblasts/myotubes.
Results:  Whereas EGFP wt-actin nicely incorporated into endogenous stress fibres and
sarcomeric structures, the mutants showed a range of phenotypes, which generally changed upon
differentiation. Many mutants appeared delocalized in myoblasts but integrated into endogenous
actin structures after 4–6 days of differentiation, demonstrating a poor correlation between the
appearance in myotubes and the severity of the disease. However, for some mutants, integration
into stress fibres induced aberrant structures in differentiated cells, like thickening or fragmentation
of stress fibres. Other mutants almost failed to integrate but formed huge aggregates in the
cytoplasm of myotubes. Those did not co-stain with alpha-actinin, a main component of nemaline
bodies found in patient muscle. Interestingly, nuclear aggregates as formed by two of the mutants
in myoblasts were found less frequently or not at all in differentiated cells.
Conclusion: Myotubes are a suitable system to study the capacity of a mutant to incorporate into
actin structures or to form or induce pathological changes. Some of the phenotypes observed in
undifferentiated myoblasts may only be in vitro effects. Other phenotypes, like aberrant stress fibres
or rod formation may be more directly correlated with disease phenotypes. Some mutants did not
induce any changes in the cellular actin system, indicating the importance of additional studies like
functional assays to fully characterize the pathological impact of a mutant.
Background
Congenital myopathies include clinical and heterogene-
ous disorders characterized by skeletal muscle weakness
with a range of severity from mild (minor muscle weak-
ness, long-term survival) to severe (neonatal onset, life-
threatening) [1]. The presence of protein rods and aggre-
gates in affected skeletal muscle fibres is used to distin-
guish nemaline and related myopathies from other
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neuromuscular disorders and to subdivide this pathology
into three classes: In actin myopathy (AM) inclusions of
excess thin filaments occupy certain areas of the sarcom-
ere. Intranuclear rod myopathy (IRM) is characterized by
the presence of rod bodies in the muscle cell nuclei and in
nemaline myopathy (NM), protein rods and aggregates
are found within the sarcoplasma of skeletal muscle fibres
[2]. Mutations in a wide spectrum of genes have been
identified to cause NM, AM and IRM, each of them encod-
ing a known component of the sarcomeric thin filament,
including nebulin (NEB), troponin (TN), tropomyosin
(TM) and actin (ACTA1). About 20 % of NM, AM and IRM
are related to skeletal muscle alpha-actin, being the sec-
ond common cause after mutations in nebulin, and
almost 100 mutations in the ACTA1 gene have been iden-
tified so far [3,4].
The seven actin mutants we selected for this study are
located in different regions of the actin molecule and rep-
resent all three known actin-linked myopathies with vary-
ing severity (Figure 1). The G15R-mutation is located in
the nucleotide binding pocket and is likely to affect ATP-
binding [5]. Like other mutants that affect residues
involved in nucleotide binding and turnover, it is linked
to actin myopathy (AM) and causes a severe, neonatal life-
threatening disorder. H40Y and V163L are located far
away from each other within the actin molecule and prob-
ably comprise very different functions. However, both of
them represent IRM-causing mutants, combined with
severe NEM for H40Y and AM for V163L. D286G and
G268R are both predicted to affect actin polymerization,
since they are situated near the hydrophobic pocket or the
hydrophobic plug, respectively, proposed to play an
important role in F-actin contacts [6]. The terms hydro-
phobic pocket and plug refer to the atomic model of the
actin filament [6]. Contacts across the two strands in the
filament are shown to be mediated in part by a hydropho-
bic plug consisting of residues 266–269, of one mono-
mer, which inserts across into a hydrophobic pocket
formed by residues 166, 169, 171, 173, 285, 289 and 40–
45, 63 and 64 of the two adjacent protomers in the oppo-
site strand (see [6]). They are causing severe NEM in
patients with profound congenital weakness and high
mortality. I64N and N115S are both associated with the
milder, typical subtype of NEM. They are located in very
different regions, with I64N being at the surface of sub-
domain II, probably affecting actin polymerization, and
N115S in a buried position, likely to affect closure of the
nucleotide binding cleft [5].
Some of the selected mutants have been expressed before,
either in NIH3T3 fibroblasts [7] or in undifferentiated
C2C12 myoblasts [8], using myc-tagged in the former or
EGFP-tagged constructs in the latter case. The phenotypes
ranged from integration into the endogenous actin net-
work to the appearance of actin accumulations within the
cytoplasm or nucleus of transfected cells. For example the
IRM-linked actin mutants V163L and H40Y produced
nuclear and cytoplasmic aggregates in fibroblasts [7], with
a similar result found after expression of EGFP-tagged
V163L and V163M mutants in C2C12 myoblasts [8],
resembling intranuclear bodies observed in patient mus-
cle samples. Accordingly, two of the NEM-causing actin
mutants, D286G and I64N, were found to produce large
cytoplasmic rods in fibroblasts, suggested that they may
be related to the giant nemaline bodies in patient skeletal
muscle fibres [7]. However, other actin isoforms did not
show any abnormality in either cell type (G268R, N115
S), raising the question, of whether short-term expression
studies in undifferentiated myoblast or fibroblast cell
lines are a suitable model to study the effect of myopathy
linked actin mutants on the cytoskeletal organization of
muscle cells.
The aim of our study was to characterize the behaviour of
actin mutants in a differentiated C2C12 myotube system.
We expect this to be a better model for myopathy since the
contribution of different actin isoforms to the sarcomeric
thin filament as the actual functional unit in the muscle
can be studied and specific causes of actin dysregulation
can be observed. We used C-terminally EGFP-tagged actin
constructs, which were transfected into C2C12 cells and
myoblasts were then differentiated for 4–6 days. Thus, the
mutants reside within the differentiating cells for several
days, matching closer the reality in human skeletal mus-
cles where an actin isoform is expressed throughout devel-
opment.
Results
Wild-type EGFP-actin integrated into stress fibres and 
sarcomeric structures in C2C12 myotubes
We expressed an EGFP-tagged version of wild-type muscle
actin (ACTA1) in C2C12 cells to examine its ability to
incorporate into endogenous actin structures. In spite of
earlier problems regarding expression of actin in differen-
tiated C2C12 cells [7] (C. Costa, doctoral thesis), we were
now able to transfect myoblasts and then differentiate
them for 4–6 days, using a modified culturing method
(see Methods). Myotubes in an advanced developed state
were identified by elongated shape, multiple nuclei and a
striated staining pattern for alpha-actinin. Alpha-actinin is
localized to the Z-discs at an early stage of myogenesis
[9,10] and immunostaining for this protein reveals very
clearly the sarcomeric structure of striated muscle fibres.
Moreover, alpha-actinin has been shown to be compo-
nent of nemaline bodies [11-13], which are commonly
found in muscles of myopathy-patients. In addition, we
used fluorescent phalloidin to probe for actin filaments
and to test for integration of the transfected actin con-
structs into endogenous F-actin.BMC Cell Biology 2007, 8:2 http://www.biomedcentral.com/1471-2121/8/2
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We classified the transfected myoblasts or differentiated
myotubes into categories depending on actin incorpora-
tion and differentiation state (see Table 1 and legend). In
general, the transfection with wild-type or mutant actin
did not affect the percentage of cells undergoing differen-
tiation (60–80%, Fig. 2,A). For wt-EGFP-actin the major-
ity of the transfected C2C12 myoblasts showed good
integration into stress fibres (75 %, Fig. 3,A); the others
containing either small cytosolic aggregates or delocalized
EGFP-actin. After 4 to 6 days of differentiation, more than
50 % of the transfected cells were able to differentiate into
myotubes, with the EGFP-actin co-localizing with endog-
enous F-actin (Fig. 3,B). A subset of cells also showed a
striated staining pattern, revealing that EGFP-actin local-
izes within the sarcomeric thin filament (Fig. 3,C; inset).
About one third of the transfected cells did not differenti-
ate, the majority of them still showing nice integration of
EGFP-actin into stress-fibres. These findings agree with a
previous study, where an EGFP-tagged version of muscle
actin was found to incorporate into stress fibres and sarco-
meric structures in C2C12 cells [8].
IRM-linked actin mutants formed nuclear and cytoplasmic 
aggregates, but could also integrate into stress fibres, 
inducing aberrant structures
In contrast to the wild-type, transfection of the IRM-
linked actin mutants H40Y and V163L showed aberrant
incorporation in more than 50 % of undifferentiated
Position of the seven mutations used in this study on the three dimensional representation of the actin monomer Figure 1
Position of the seven mutations used in this study on the three dimensional representation of the actin mono-
mer. The seven mutations selected for this study are represented on the ribbon diagram of the actin molecule from PDB code 
1ATN. Calcium is shown in magenta and the adenine of ATP is green with the phosphates in orange. For the side chain atoms, 
carbon is yellow, nitrogen is blue and oxygen is red.
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C2C12 cells (56 % for H40Y, 75 % for V163L, Table 1).
Similar to previous studies [7,8], nuclear aggregates have
been found in a large subset of those cells, which have
been proposed to be related to the intranuclear rods
present in skeletal muscles of IRM patients (Fig. 4,A; long
arrow). Aggregates showed some co-staining with phalloi-
din (Fig. 4,A"), indicating the presence of filamentous
actin. In almost no case was co-localization of alpha-
actinin with aggregates observed, however, in V163L-
transfected cells sometimes a very faint co-staining with
alpha-actinin could be detected (Fig. 4,D'; long arrow). In
contrast to some previous studies [7,8] both mutants were
also able to incorporate into stress fibres in a certain por-
tion of C2C12 myoblasts.
After differentiation, 40 % of the transfected myotubes
showed good incorporation of mutant actin (Fig. 4,B,E).
However, almost half of H40Y-transfected, differentiated
cells showed stress fibres with aberrant structures (Table
1). In some cases, stress fibres appeared to be fragmented
(Fig. 4,B; short arrow), others were thickened and had a
wavy appearance (Fig. 4,C; long arrow). Aberrant stress
fibres were also observed in many of the V163L-trans-
fected myotubes (Fig. 4,E; short arrow), but here the phe-
notypes were more mixed, with some cells showing
cytosolic and nuclear aggregates, similar to undifferenti-
ated cells (Fig. 4,D; long arrow). Notably, for V163L,
nuclear aggregates were found less frequently in differen-
tiated cells and not at all in H40Y-transfected myotubes,
indicating that either cells containing H40Y-actin accu-
mulations in the nucleus stay in an undifferentiated state
or nuclear aggregates disappear upon differentiation.
Thus, we confirmed the formation of nuclear aggregates
being the most striking feature of IRM-linked mutants in
myoblasts, however, in differentiated cells aberrant stress
fibres became the dominant phenotype.
Actin mutants linked to typical NEM induced phenotypes 
in undifferentiated cells, but integrated well into 
sarcomeric structures in later differentiation states
Next, we characterized two mutants, N115S- and I64N-
actin, that are linked to the generation of NEM in patient
muscles. I64N-actin produced diffuse cytoplasmic stain-
ing in a large proportion of transfected myoblasts (85 %,
Table 1), with some of the cells also showing cytoplasmic
rods that did not co-stain with phalloidin or alpha-actinin
(Fig. 5,A; long arrow). N115S-actin had a milder effect,
but still exhibited poor integration in almost 50 % of the
cells, with either delocalization or formation of small
cytoplasmic aggregates that did not stain with phalloidin
(Fig. 5,C; long arrow). The localization of mutant actins
changed considerably upon differentiation. 50 % of the
I64N-transfected cells differentiated into myotubes and
showed nice integration of the mutant actin into sarcom-
eric structures, similar to the wild-type (Fig. 5,B; inset).
Only a small proportion of differentiated myotubes
Table 1: Phenotypes of myopathy-linked actin mutants expressed in C2C12 myoblasts and differentiated myotubes.
wt H40Y V163L 164N N115S G268R D268R G15R
und. diff. und. diff. und. diff. und. diff. und. diff. und. diff. und. diff. und. diff.
n 189 219 174 222 203 189 182 128 52 89 135 127 140 110 114 108
c a t .  1  % 7 45 7 4 44 1 2 54 0 1 55 5 5 26 7 6 57 2 1 43 5 5 84 2
cat. 2 % 26 3 56 36 75 26 85 5 48 5 35 8 86 44 42 30
aggr. 32 33 57 19 8 38 11 29 36 75 30 60 17 100 94 19
n u c l . a g g r . 00 3 1 0 5 6 3 8 00 00 00 00 00
deloc. 68 11 27 4 42 2 92 43 64 0 70 20 84 0 10 0
a b e r r .  S F 06 7 09 1 06 8 05 7 02 5 02 0 01 2 08 8
c a t .  3  % 3 35 7 2 32 21 77 1 1
cat. 4 % 7 18 25 17 2 2 11 18
aggr. 38 38 35 27 100 100 100 42
n u c l . a g g r .02 1 5 8 00000
d e l o c . 5 6 828 3 0000
a b e r r .  S F1 3 4 9 4 0 00088 4
Table 1 shows a summary of data from experiments where EGFP-tagged actin constructs were transfected into C2C12 cells and myoblasts were 
then differentiated for 4–6 days. After immunostaining, transfected myoblasts or differentiated myotubes were classified into categories depending 
on how well the EGFP-actin was integrated and the differentiation state of the cells:
myoblasts (und.): category 1: cells with good integration of EGFP-actin construct
category 2: cells with poor integration of EGFP-actin construct, divided into different subgroups: cytoplasmic aggregates (aggr.), nuclear aggregates 
(nucl. aggr.), delocalization (deloc.), aberrant stress fibres (aberr. SF)
myotubes (diff.): category 1: differentiated cells with good integration of EGFP-actin consructs
category 2: differentiated cells with poor integration (see subgroups above)
category 3: undifferentiated cells with good integration
category 4: undifferentiated cells with poor integration (see subgroups above)
For every construct, the total number of transfected cells that were counted is also stated (n).BMC Cell Biology 2007, 8:2 http://www.biomedcentral.com/1471-2121/8/2
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exhibited phenotypes such as delocalization, aggregates
and wavy stress fibres. Most of the cells with such an
appearance stayed in an undifferentiated state (Table 1).
Myotubes expressing N115S-actin were even less affected.
The majority of them were well differentiated and incor-
porated the mutant actin nicely into stress fibres and sar-
comeric structures (Fig. 5,D). The proportion of cells
showing no aberrant structures was even higher than with
wt-actin (67 % vs 57 %), indicating no visible defect of
this isoform to contribute to endogenous actin structures.
Thus, we find that most of the myopathy mutant actins
incorporate better in differentiated myotubes than in
myoblasts or fibroblasts (Fig. 2,A).
Two actin mutants that cause a severe form of NEM 
induced very different phenotypes in differentiated 
myotubes
The mutants D286G-actin and G268R-actin were
expected to behave similarly to each other in cultured
cells, since they are both predicted to affect actin polymer-
ization and cause severe forms of NEM in patients. How-
ever, their phenotypes even in undifferentiated myoblasts
were very different. G268R-actin behaved similar to wt-
actin with more than 60 % of the cells integrating the
mutant into stress fibres (Fig. 6,A). In about one third of
transfected cells, small cytosolic aggregates or delocaliza-
tion of the mutant actin were observed. With D286G-
actin, only 14 % of the cells showed normal integration.
In almost all of the others, diffuse cytoplasmic staining
indicated a delocalized actin mutant (Fig. 6,C), a result
very similar to the phenotype of I64N-actin transfected
cells (see above).
Upon differentiation, the differences between the two
mutants became even more distinct. 44 % of D286G-actin
transfected cells differentiated into myotubes that contain
huge cytoplasmic rods (Fig. 6,D,E; long arrows) and
sometimes additionally showed wavy stress fibres (Fig.
6,E; short arrow). Similar to the I64N-mutant, the rods
did not co-stain with phalloidin or alpha-actinin. For
G268R-actin a clear majority of myotubes showed incor-
poration of the mutant into sarcomeric structures (Fig.
6,B), a proportion considerably higher than with wt-actin.
The phenotypes of actin mutants expressed in C2C12cells differed before and after differentiation Figure 2
The phenotypes of actin mutants expressed in C2C12cells differed before and after differentiation. A) Percent-
ages of cells with good integration of the expressed EGFP-tagged actin construct (category 1 cells, see Table 1). Most of the 
mutant actin isoforms showed better incorporation into the actin cytoskeleton in differentiated myotubes than in undifferenti-
ated cells. B) Distribution of different phenotypes of the expressed EGFP-tagged actin constructs in affected C2C12 cells 
before and after differentiation (category 2 cells, see Table 1). Left bars represent undifferentiated myoblasts, right bars differ-
entiated myotubes. The bars are subdivided, showing the different types of phenotypes that were observed. In some cells, 
more than 1 phenotype was observed, resulting in total percentages of more than 100%.
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In spite of its fatal effects in patients, the G268R-actin iso-
form thus showed no defects in contributing to sarcom-
eric actin structures in differentiated muscle cells. Thus,
the ability of mutant actin to incorporate into actin struc-
tures in differentiated myotubes does not necessarily cor-
relate with the severity of the mutation.
The AM-linked G15R-actin mutant caused accumulations 
of polymerized actin in myotubes
We also characterized the AM-linked G15R mutant, which
is predicted to have defects in ATP-binding. When trans-
fected into undifferentiated myoblasts, many cells had
small aggregates in the cytoplasm that mostly stained with
Expression of wild-type actin-EGFP Figure 3
Expression of wild-type actin-EGFP. Wild-type muscle actin with a C-terminal EGFP-tag was expressed in undifferentiated 
C2C12 myoblasts (A) or myotubes that have been differentiated for 4–6 days (B, C). Expressed actin_EGFP co-localized with 
endogenous filamentous actin, as visualized with phalloidin in myoblasts (A, A") and myotubes (B, B"). In a subset of myotubes, 
a striated staining-pattern for alpha-actinin revealed sarcomeric structures, with expressed EGFP-actin co-localizing within the 
sarcomeric thin-filament (C, C"; inset). (Scale bars: 5 μm)BMC Cell Biology 2007, 8:2 http://www.biomedcentral.com/1471-2121/8/2
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Expression of the IRM-linked H40Y- and V163L-actin mutants Figure 4
Expression of the IRM-linked H40Y- and V163L-actin mutants. EGFP-tagged H40Y- (A-C) and V163L- (D, E) actin 
mutantswere expressed in C2C12 myoblasts (A) and differentiatedmyotubes.(B-E). EGFP fluorescence showed intranuclear (A; 
long arrows) and cytoplasmic aggregates (A; short arrow) formed by the H40Y-mutant in undifferentiated cells, with some co-
staining with phalloidin (A"; arrows), but not with alpha-actinin (A'; arrows). A similar phenotype was observed for the V163L-
isoform (not shown). In myotubes, some integration of EGFP-actin into stress fibres or sarcomeric structures was observed 
for both, H40Y- actin (B-B"; long arrows) and V163L-actin mutants (E, inset). However, in many differentiated cells, aberrant 
stress fibres were produced with a thickened and wavy appearance (C, C" long arrows; E, E", short arrows). The H40Y mutant 
might also induce fragmentation of stress fibres (B, B"; short arrow), but this could also be a short cytoplasmic rod. The V163L-
mutant also formed nuclear aggregates in some myotubes (D; long arrow) that co-stained with phalloidin (D"; long arrow) and 
also very faintly with alpha-actinin (D'; long arrow). Nuclear aggregates were never found with the H40Y-mutant after differen-
tiation. (Scale bars: 5 μm)BMC Cell Biology 2007, 8:2 http://www.biomedcentral.com/1471-2121/8/2
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Expression of the NEM-linked I64N- and N115S-actin mutants Figure 5
Expression of the NEM-linked I64N- and N115S-actin mutants. EGFP-tagged I64N- (A, B) and N115S- (C, D) actin 
mutantswere expressed in C2C12 myoblasts (A, C) and differentiated myotubes (B, D). Both mutants showed poor integration 
in undifferentiated cells: EGFP fluorescence revealed delocalization in many myoblasts (A, C; short arrows). I64N-actin also 
produced large rods (A; long arrow), whereas N115S-actin formed smaller, punctuate aggregates in the cytoplasm of some 
cells (C; long arrow), in both cases not co-staining with phalloidin or alpha-actinin (A', A"; C', C"; long arrows). After differen-
tiation both mutants incorporated into actin structures such as stress fibres (D-D"; long arrows) and sarcomeric thin filament 
bundles (B, B', inset). (Scale bars: 5 μm)BMC Cell Biology 2007, 8:2 http://www.biomedcentral.com/1471-2121/8/2
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Expression of the NEM-linked G268R and D286G-actin mutants Figure 6
Expression of the NEM-linked G268R and D286G-actin mutants. Expression of the EGFP-tagged G268R-actin in 
either undifferentiated myoblasts (A) or differentiated myotubes (B) lead to good integration of the actin mutant into endog-
enous actin structures. In contrast, the D286G-isoform stayed delocalized in the majority of transfected myoblasts (C). After 
differentiation, EGFP fluorescence revealed the formation of giant rods in the cytoplasm of D286G-transfected myotubes (D, E; 
long arrows) that did not co-stain with phalloidin or alpha-actinin (D', D", E', E"; long arrows). In some myotubes, mutant actin 
integrated into stress fibres, but their structures were abnormally wavy (E, E"; short arrows).BMC Cell Biology 2007, 8:2 http://www.biomedcentral.com/1471-2121/8/2
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phalloidin (Fig. 7,A,A"; long arrows), but more than 50 %
also showed good incorporation of the mutant into stress
fibres. After differentiation, a more severe phenotype
appeared. In one third of the myotubes noticeable
changes in actin structures could be observed, especially
wavy and extremely thickened stress fibres (Fig. 7,B,C;
long arrows). In some cases this resulted in big accumula-
tions of polymerized actin that co-stained with phalloidin
and are possibly reminiscent of actin accumulations seen
in patient skeletal muscles.
Discussion
We studied the behaviour of 7 myopathy-related actin
mutants in C2C12 myotubes, resulting in a wide range of
different phenotypes that in many cases changed during
differentiation of the cells. Previous studies have mainly
used undifferentiated myoblast or fibroblast cell lines
[7,8], although Ilkovski et al. [8] have studied V163L and
four other mutants in myotubes. In general, the pheno-
types described in these studies matched our findings in
the undifferentiated myoblasts, with some differences in
how pronounced the effect appeared in the cells (see
below).
Notably, none of the mutants affected differentiation, the
total proportion of differentiated cells was always at least
60% (the value for wt-actin), for some mutants even as
high as 80% (G268R, D286G, Table 1). However, the
appearance of most of the mutants investigated differed
before and after differentiation (Fig. 2).
Generally, most of the mutant actin isoforms showed bet-
ter incorporation into the actin cytoskeleton in differenti-
ated myotubes than in undifferentiated myoblasts (Fig.
2,A). This interesting result raises the question, of whether
some of the previously described effects are only observed
after short-term expression of actin mutants in an in vitro
cell culture model, but are not relevant for the real situa-
tion in skeletal muscles.
The mutants I64N and N115S are not readily integrated
into stress fibres, since they produced a diffuse cytoplas-
mic staining in the majority of undifferentiated myob-
lasts. For the I64N-mutant this differs slightly from the
result by Costa et al., who found some integration into
fibroblast stress fibres as well as long cytoplasmic rods [7].
Cytoplasmic rods were also observed in our study in a
smaller subset of myoblasts, so we suspect these small dif-
ferences in appearance may be due to the use of different
epitope tags or vectors with somewhat different expres-
sion levels (N-terminal myc-tag in Costa et al. and C-ter-
minal EGFP-tag in our study). In case of I64N, poor
integraton into stress fibres fits nicely with the predicted
polymerization defect [5], also confirmed biochemically
in co-polymerization experiments with wt-actin [7]. The
N115S mutation is likely to affect the closure of the nucle-
otide binding cleft, a defect that could also result in a
decreased polymerization propensity [5]. However, both
isoforms are capable to contribute to sarcomeric struc-
tures, since they showed good integration after several
days of differentiation (Fig. 5). Only in 5 % of the myo-
tubes an abnormal phenotype could be observed.
Generally, there is poor correlation between the number
of myotubes with aberrant actin structures and the sever-
ity of the disease caused by a specific mutant. The G268R
mutant behaved similarly to the wildtype in undifferenti-
ated myoblasts (Fig. 6,A), confirming the results described
in the other expression studies [7,8]. After differentiation,
even 72 % of the cells showed good incorporation into
actin structures (versus 57% for wt-actin), despite being
linked to a severe form of NEM. Because of their patholog-
ically unremarkable phenotype in differentiated myo-
tubes, the NEM-linked mutants I64N, N115S and G268R
are likely to be incorporated into sarcomeric structures in
patient muscles. Therefore, we suggest that they exert a
dominant effect via a functional defect (e.g. contraction
defect), rather than mislocalisation. Alternatively, differ-
entiation for 4–6 days might still be not sufficient to show
aberrant structures produced by these mutants.
The D286G mutant, which is linked to severe NEM,
appeared delocalized in most of the myoblasts (Fig. 6,C),
similar to I64N and N115S. However, unlike the other
mutants it did not integrate in the majority of myotubes
during differentiation, but instead formed big, rod-like
aggregates in the cytoplasm (Fig. 6,D,E; long arrows).
These rods did not stain with phalloidin, and appeared
similar to the aggregates described by Costa et al. in
fibroblasts. D286 is located near the hydrophobic pocket,
so a profound polymerization defect is likely, which could
result in the aggregation of unpolymerized actin. This pre-
diction fits well to the behaviour of the mutant within dif-
ferentiated cells and to the severity of the disease. It would
be interesting to investigate whether patients with this
mutation had a higher level of aggregates within muscle
biopsies and whether these contained filamentous actin
or aggregated actin.
One characterizing feature of NM and also used for diag-
nostic means is the presence of nemaline rods and bodies
in the sarcoplasma of patient skeletal muscles. These giant
accumulations are thought to emerge from Z-lines and
apart from actin thin filaments are largely composed of
alpha-actinin and other Z-line proteins [1,11,13]. Since
the transfection of several NEM-linked mutants resulted
in the formation of aggregates within the cytoplasm of the
cells (Fig. 5, 6), it has been hypothesized that these corre-
spond to the cytoplasmic nemaline bodies found in
patient skeletal muscles [7]. However, in our expressionBMC Cell Biology 2007, 8:2 http://www.biomedcentral.com/1471-2121/8/2
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studies there are clearly different kinds of accumulations:
aggregates that co-stain with phalloidin (V163L, H40Y,
G15R), big rods that do not co-stain (I64N, D286G), and
small, punctuate aggregates as sometimes found with the
wild-type or the phenotypically unremarkable mutants
(N115S, G268R), also not co-staining with phalloidin.
Aggregates that stain with phalloidin contain actin fila-
ments, as it would be expected in nemaline bodies. The
Expression of the AM-linked G15R-actin mutant Figure 7
Expression of the AM-linked G15R-actin mutant. Expression of the EGFP-tagged G15R-actin isoform in myoblasts pro-
duced small cytoplasmic aggregates in many cells (A; long arrow), co-staining with phalloidin but not with alpha-actinin (A', A"; 
long arrows). In differentiated myotubes, the mutant actin gets integrated, but produced extremely thickened stress fibres (B, 
B"; long arrows). Sometimes this resulted in big accumulations of polymerized actin that co-stained with phalloidin (C, C"; long 
arrows).BMC Cell Biology 2007, 8:2 http://www.biomedcentral.com/1471-2121/8/2
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lack of co-staining could either indicate accumulations
that are composed of unpolymerized actin or that are not
accessible for phalloidin. To further investigate the corre-
lation between the aggregates found in in vitro studies and
in patient muscles we performed co-staining with alpha-
actinin as the main component of nemaline bodies. Gen-
erally, there was no co-localization of alpha-actinin with
any kind of aggregates formed by the actin mutants, espe-
cially the giant rods found with the D286G mutant (Fig.
6,D',E'). Very rarely, some co-staining with aggregates pro-
duced by the V163L-isoform was observed (Fig. 4,D'),
however, since that occurred only in some cases and was
always very faint, the significance of this finding is not
clear. The fact that no co-staining was found in the differ-
entiated myotubes is especially interesting, since here
early sarcomeric structures including Z-lines have already
been constituted, thus providing the original environ-
ment for the formation of nemaline bodies. One possible
explanation for the lack of co-staining is that the accumu-
lations are not accessible for the antibody. However, we
suggest that the propensity of some mutants to form dif-
ferent kinds of rods and aggregates in vitro might reflect a
specific molecular defect rather than having any connec-
tion with the nemaline bodies found in patient muscles.
This view is supported by the fact, that the appearance of
nemaline rods can vary from 1 % to virtually all fibres and
does not correlate with the degree of muscle weakness
[14]. Moreover, they are also found in other myopathy
diseases as well as in small numbers of normal muscles
[1].
A slightly different situation applies for intranuclear rods.
In our study, the only mutants that produced intranuclear
aggregates are the H40Y and V163L-isoforms, which also
cause IRM in patients [15]. This agrees with the study from
Ilkovski [8] who found that high levels of insoluble
V163L appeared very early after transfection of myoblasts
and persisted in myotubes. This indicates that the ability
to form accumulations within the nucleus could be an
inherent characteristic of some mutants and directly cor-
related to the appearance of IRM in patients. However, Ilk-
ovski et al. reported nuclear aggregates in myoblasts
transfected with the R183G-mutant, which were not
found in the muscle biopsy of a patient suffering from
severe NEM caused by this isoform [8]. An issue here
could be that only limited biopsy material is available
from patients, and biopsies tend to be highly variable.
Interestingly, nuclear aggregates produced by H40Y-actin
in myoblasts and fibroblasts were never observed in dif-
ferentiated cells, and also did not represent the dominant
phenotype in V163L-transfected myotubes (Fig. 2,B),
arguing against a direct relation between those aggregates
and the rods observed in patient muscles. The molecular
reason for the formation of intranuclear rods is still elu-
sive, but a connection has been suggested to the previ-
ously reported stress-induced translocation of actin into
the nucleus [16,17]. Similar to nemaline bodies, intranu-
clear rods might be the result of a general response of skel-
etal muscle fibres to certain pathological situations. Thus,
the appearance of intranuclear aggregates in vitro might be
an indicator for a link to IRM, but cannot be used as an
established diagnostic tool.
In addition to rod formation there was another interesting
feature predominantly seen in the differentiated myo-
tubes, that is the appearance of aberrant stress fibres. In no
case did we observe wavy or otherwise abnormal stress
fibres in the myoblasts, but especially for the H40Y-,
V163L- and the AM-linked G15R-mutant they were
present in a large subset of myotubes (Fig. 2,B). At least
the V163L actin also appeared striated, as if incorporated
into sarcomere-like structures (Figure 3, inset). The exact
phenotype ranges from fragmented and shortened to
wavy and thickened stress fibres. The lack of those aber-
rant structures in undifferentiated cells indicates that they
develop after an initial integration of mutant molecules
into endogenous actin structures, which eventually
induce the formation of abnormal capacities. Fig. 4,B sup-
ports this view, since the middle part of the myotube
shows normal incorporation of the H40Y-mutant into
stress fibres (long arrow), whereas at the far end of the
cell, some fragmentation might have occurred (short
arrow). Aberrant stress fibres are not seen in undifferenti-
ated cells, but appear for all of the mutants investigated in
varying proportions within differentiated myotubes (Fig.
2,B). The percentage of cells containing wavy stress fibres
seem to be loosely linked to the severity of the disease,
with the highest numbers coming up for the mutants
H40Y, G15R and V163L, all causing severe forms of
myopathy. A "poisonous" effect of mutant actin isoforms
has been previously suggested because of the fact that iso-
forms were found to be expressed and present within
insoluble actin filaments from patient muscles [8] and the
recessive nature of "loss-of function" actin mutants with
severely defective folding [7].
Unfortunately, we cannot rule out the possibility that dif-
ferential expression levels among the mutants may con-
tribute to the phenotypes seen. The best system would use
the endogenous actin promoter to express mutant actins
in cells, but we have not yet succeeded in this aim.
Conclusion
Differentiated myotubes are a suitable system to charac-
terize myopathy-linked actin mutants. Compared to
undifferentiated cells, they show more reliably the capac-
ity of different mutants to incorporate into actin structures
or to form or induce pathological changes. The observa-
tion of actin isoforms in an environment closer to the real-
ity in skeletal muscles can give hints about whichBMC Cell Biology 2007, 8:2 http://www.biomedcentral.com/1471-2121/8/2
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properties of the mutants are likely to cause disease in
patients (aberrant stress fibres) and which might be in
vitro effects nuclear or cytoplasmic aggregates. However,
early myotubes are not a model of the situation in skeletal
muscles, where additional pathological features may
develop as a result of muscular responses (e.g. nemaline
bodies). The study of the behaviour of a mutant in myo-
tubes is only one part to fully characterize and predict the
impact of an actin mutation, further in vitro studies like
functional assays or the use of mouse models are also
needed.
Methods
Construction of the EGFP-tagged alpha-actin myopathy 
mutants
ACTA1 mutations were made with the Quick Change site
directed mutagenesis kit (Stratagene, UK) as described [7].
C-terminal EGFP-tagged wild-type (kind gift from Dr.
Nigel Laing) and actin mutants were cloned by PCR using
the actin mutants in the pcDNA3.1 vector as template, a 5'
primer containing a XhoI site and a 3' primer containing
the EcoRI site. These fragments were then ligated into the
XhoI/EcoRI-digested pEGFP-N1 vector (Clontech, USA).
Constructs were sequenced to verify the complete ACTA1
coding sequence and correct introduction of the desired
mutation.
Cell culture and transfection
C2C12 myoblasts were cultured at 37°C in humidified
5% CO2 atmosphere in a proliferation medium composed
of Dulbecco's modified Eagle's medium (DMEM 41966,
Gibco BRL, UK), supplemented with 10% fetal bovine
serum (Sigma, UK).
For expression studies, trypsinized suspensions of C2C12
cells at 0.5 × 105 cells per ml were seeded on 13-mm glass
coverslips coated with gelatine. These were prepared by
incubating the coverslips for 5 min in PBS containing 1%
gelatine (from bovine skin, Sigma, UK); the gelatine-
buffer was then taken off and the coverslips dried for 1
hour under sterile conditions. Alternatively, 13-mm ther-
manox coverslips (Nalgene Nunc, Naperville, IL) were
used.
After 24 h of incubation, the vectors encoding the C-ter-
minally EGFP-tagged actin constructs were transfected
using Lipofectamine 2000 transfection reagent (Invitro-
gen, UK), according to the manufacturer's protocol.
Duplicate coverslips were used for every transfected actin
construct. After further 24 h incubation, one of the cover-
slips was taken out and cells were fixed and stained for
immunofluorescence (D0, undifferentiated myoblasts).
Cells on remaining coverslips were washed twice in differ-
entiation medium, composed of DMEM supplemented
with 2% horse serum (Sigma, UK) and then further incu-
bated in this medium for 4–6 days (D4-6, differentiated
myotubes).
Immunofluorescence and microscopy
At given time points, cells plated on coverslips were
washed three times in PBS and fixed with 4% formalde-
hyde for 10 min at room temperature. Free aldehyde
groups were blocked with 50 mM NH4Cl for 10 min and
cells were permeabilized in PBS containing 0.1% Triton X-
100 for 4 min. Cells were incubated with anti sarcomeric
alpha-actinin (A7811, Sigma, UK) for 20 min at room
temperature, followed by a Texas-red anti-mouse second-
ary antibody (Jackson ImmunoResearch) and Alexa 350-
phalloidin (Invitrogen, UK) for 20 min. In some cases,
Hoechst staining was applied (0.4 μg/ml) to visualize
nuclei and to confirm the presence of intranuclear aggre-
gates. Finally, coverslips were rinsed three times in water
and mounted onto a slide with 5 μl Mowiol (Calbio-
chem) plus Antifade.
Stained cells were examined with a Zeiss microscope
(Zeiss, Jena, Germany) using either a 63× or a 100× objec-
tive. Images were recorded with a Hamamatsu C4880
camera (Bridgewater, NJ) and processed using Photoshop
software (Adobe, USA).
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